Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases

Vista sencilla de ítem
dc.creatorCheong, Dorothy H.J.
dc.creatorTan, Daniel W.S.
dc.creatorWong, Fred W.S.
dc.creatorTran, Thai
dc.date.accessioned2020-08-20T16:02:27Z
dc.date.available2020-08-20T16:02:27Z
dc.date.created2020-08
dc.description.abstractenglishArtemisinins are sesquiterpene lactones with a peroxide moiety that are isolated from the herb Artemisia annua. It has been used for centuries for the treatment of fever and chills, and has been recently approved for the treatment of malaria due to its endoperoxidase properties. Progressively, research has found that artemisinins displayed multiple pharmacological actions against inflammation, viral infections, and cell and tumour proliferation, making it effective against diseases. Moreover, it has displayed a relatively safe toxicity profile. The use of artemisinins against different respiratory diseases has been investigated in lung cancer models and inflammatory-driven respiratory disorders. These studies revealed the ability of artemisinins in attenuating proliferation, inflammation, invasion, and metastasis, and in inducing apoptosis. Artemisinins can regulate the expression of pro-inflammatory cytokines, nuclear factor-kappa B (NF-κB), matrix metalloproteinases (MMPs), vascular endothelial growth factor (VEGF), promote cell cycle arrest, drive reactive oxygen species (ROS) production and induce Bak or Bax-dependent or independent apoptosis. In this review, we aim to provide a comprehensive update of the current knowledge of the effects of artemisinins in relation to respiratory diseases to identify gaps that need to be filled in the course of repurposing artemisinins for the treatment of respiratory diseases. In addition, we postulate whether artemisinins can also be repurposed for the treatment of COVID-19 given its anti-viral and anti-inflammatory properties.spa
dc.format.extent15 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.doihttps://doi.org/10.1016/j.phrs.2020.104901spa
dc.identifier.issn1043-6618spa
dc.identifier.otherhttps://www.sciencedirect.com/science/article/pii/S1043661820312093?via%3Dihub#kwd0010spa
dc.identifier.urihttps://hdl.handle.net/20.500.12010/12016
dc.publisherPharmacological Researchspa
dc.rights.accessrightsinfo:eu-repo/semantics/embargoedAccessspa
dc.rights.localAcceso restringidospa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectEnfermedades respiratoriasspa
dc.subject.keywordRespiratory diseasesspa
dc.subject.keywordLungspa
dc.subject.keywordCell proliferationspa
dc.subject.keywordInflammationspa
dc.subject.keywordChemical compounds studied in this article Artemisinin (PubChem CID: 68827)spa
dc.subject.keywordDihydroartemisinin (PubChem CID: 139073990)spa
dc.subject.keywordArtesunate (PubChem CID:156252)spa
dc.subject.keywordArtemisitene (PubChem CID: 11000442)spa
dc.subject.keywordArtemether (PubChem CID: 68911)spa
dc.subject.keywordArteether (PubChem CID: 3000469)spa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.subject.lembArtemisininspa
dc.titleAnti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseasesspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.localArtículospa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
Anti-malarial-drug--artemisinin-and-its-derivatives-for-_2020_Pharmacologica.pdf
Tamaño:
2.38 MB
Formato:
Adobe Portable Document Format
Descripción:
Documento reservado
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
2.87 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Documentos científicos relacionados a la COVID-19

Carrera 4 # 22-61 Teléfono: (+57) 601 242 7030 - 018000111022 Fax: (+57) 601 561 2107 Bogotá D.C., Colombia

Fundación Universitaria de Bogotá Jorge Tadeo Lozano | Vigilada Mineducación

Institución de educación superior privada, de utilidad común, sin ánimo de lucro y su carácter académico es el de Universidad

Reconocimiento personería jurídica: Resolución 2613 del 14 de agosto de 1959 Minjusticia.

Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

Software DSpace copyright © 2002-2026 LYRASIS